Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFOX Study: Oxygen Therapy During Exertion in Fibrotic Interstitial Lung Disease
2023-510440-20-00Phase 4Authorised
- Sponsor
- Parc de Salut Mar
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxygen in pulmonary fibrosis (PF) (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Change in steps per day. Planned start May 2024; status: authorised.
02
Drugs
oxygen
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on 2023-510440-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510440-20-00.